Effect of [68Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial
James P Buteau MD, Daniel Moon MBBS, Michael T Fahey PhD, Matthew J Roberts PhD, Narjess Ayati MD, Nathan Papa PhD, Prof Declan G Murphy MBBCh, Prof Veeru Kasivisvanathan PhD, Prof Haryana M Dhillon PhD, Yang T Du MBBS, Philip Dundee FRACS, Jessica Foudoulis MHIM, David Hennes MD, Anthony C Hutton FRACS, Jordan Idiare MBBS, Greg Jack FRACS, Sheshang Kamath FRACS, Sophie N Lee PhD, Su-Faye Lee FRANZC, Prof Sze Ting Lee PhD, Alex Zheng
The Lancet Oncology